Norinchukin Bank The boosted its stake in shares of Monsanto (NYSE:MON) by 2.1% during the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 116,748 shares of the basic materials company’s stock after buying an additional 2,400 shares during the period. Norinchukin Bank The’s holdings in Monsanto were worth $13,634,000 as of its most recent SEC filing.
Other hedge funds also recently made changes to their positions in the company. Capital International Investors grew its stake in shares of Monsanto by 10.3% during the 3rd quarter. Capital International Investors now owns 9,344,430 shares of the basic materials company’s stock worth $1,119,650,000 after acquiring an additional 872,377 shares in the last quarter. Independent Franchise Partners LLP grew its stake in shares of Monsanto by 1.8% during the 3rd quarter. Independent Franchise Partners LLP now owns 4,185,504 shares of the basic materials company’s stock worth $501,507,000 after acquiring an additional 72,500 shares in the last quarter. Janus Henderson Group PLC grew its stake in shares of Monsanto by 57.1% during the 3rd quarter. Janus Henderson Group PLC now owns 2,342,693 shares of the basic materials company’s stock worth $280,696,000 after acquiring an additional 851,369 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Monsanto by 2.2% during the 3rd quarter. Legal & General Group Plc now owns 2,339,225 shares of the basic materials company’s stock worth $280,276,000 after acquiring an additional 49,682 shares in the last quarter. Finally, Harding Loevner LP grew its stake in shares of Monsanto by 140.0% during the 3rd quarter. Harding Loevner LP now owns 2,294,152 shares of the basic materials company’s stock worth $111,903,000 after acquiring an additional 1,338,271 shares in the last quarter. Hedge funds and other institutional investors own 73.70% of the company’s stock.
In related news, EVP Steven Mizell sold 8,100 shares of the firm’s stock in a transaction on Tuesday, January 9th. The shares were sold at an average price of $119.35, for a total value of $966,735.00. Following the completion of the transaction, the executive vice president now directly owns 56,743 shares of the company’s stock, valued at $6,772,277.05. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.70% of the stock is currently owned by company insiders.
Monsanto (MON) opened at $120.79 on Monday. Monsanto has a 52 week low of $108.51 and a 52 week high of $123.15. The company has a quick ratio of 0.79, a current ratio of 1.28 and a debt-to-equity ratio of 1.05. The firm has a market cap of $53,244.33, a price-to-earnings ratio of 21.08, a P/E/G ratio of 1.73 and a beta of 1.01.
Monsanto (NYSE:MON) last released its earnings results on Thursday, January 4th. The basic materials company reported $0.41 earnings per share for the quarter, missing the consensus estimate of $0.42 by ($0.01). Monsanto had a net margin of 16.38% and a return on equity of 40.13%. The firm had revenue of $2.66 billion during the quarter, compared to the consensus estimate of $2.77 billion. During the same period in the prior year, the business posted $0.21 earnings per share. Monsanto’s quarterly revenue was up .3% compared to the same quarter last year. research analysts anticipate that Monsanto will post 5.76 EPS for the current fiscal year.
The company also recently announced a quarterly dividend, which will be paid on Friday, April 27th. Investors of record on Friday, April 6th will be paid a $0.54 dividend. The ex-dividend date of this dividend is Thursday, April 5th. This represents a $2.16 annualized dividend and a dividend yield of 1.79%. Monsanto’s dividend payout ratio is presently 39.85%.
Several equities analysts have recently weighed in on MON shares. Zacks Investment Research cut shares of Monsanto from a “buy” rating to a “hold” rating in a research note on Monday, December 11th. Wells Fargo & Co reaffirmed a “market perform” rating and set a $128.00 price target (up from $118.00) on shares of Monsanto in a research note on Wednesday, January 17th. Deutsche Bank reaffirmed a “buy” rating on shares of Monsanto in a research note on Tuesday, January 16th. Finally, Royal Bank of Canada reaffirmed a “hold” rating and set a $128.00 price target on shares of Monsanto in a research note on Wednesday, November 15th. Eleven investment analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. Monsanto has a consensus rating of “Hold” and an average price target of $127.30.
ILLEGAL ACTIVITY WARNING: “Monsanto (MON) Shares Bought by Norinchukin Bank The” was first posted by The Ledger Gazette and is owned by of The Ledger Gazette. If you are reading this story on another publication, it was copied illegally and reposted in violation of international trademark & copyright law. The legal version of this story can be accessed at https://ledgergazette.com/2018/02/19/monsanto-mon-shares-bought-by-norinchukin-bank-the.html.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Want to see what other hedge funds are holding MON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Monsanto (NYSE:MON).
Receive News & Ratings for Monsanto Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto and related companies with MarketBeat.com's FREE daily email newsletter.